Pioneer Group
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NuVision Biotherapies
5 Feb 2026
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.
ImmuONE
13 Mar 2025
ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
Pioneer Group
More venture news
- 5 May 2026
SugaROxSugaROx lands £2.5m in funding from The Mosaic Company to develop crop biostimulants that improve yield and quality
EquityAgriculture - 5 May 2026
NunaBioNunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
EquityLife Sciences - 29 Apr 2026
EcodetectEcodetect secures £500k in funding from investors for marine monitoring technology in offshore renewables
EquityClimate
